PSUSA/00010347/202310 - periodic safety update report single assessment
atorvastatin
PSUSA
Human
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Atorvastatin : CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00010347/202310
English (EN) (75.02 KB - PDF)
български (BG) (100.21 KB - PDF)
español (ES) (41.27 KB - PDF)
čeština (CS) (123.17 KB - PDF)
dansk (DA) (112.33 KB - PDF)
Deutsch (DE) (133.08 KB - PDF)
eesti keel (ET) (76.65 KB - PDF)
ελληνικά (EL) (97.98 KB - PDF)
français (FR) (103.57 KB - PDF)
hrvatski (HR) (53.69 KB - PDF)
íslenska (IS) (102.92 KB - PDF)
italiano (IT) (86.28 KB - PDF)
latviešu valoda (LV) (130.72 KB - PDF)
lietuvių kalba (LT) (197.61 KB - PDF)
magyar (HU) (133.38 KB - PDF)
Malti (MT) (102.33 KB - PDF)
Nederlands (NL) (115.42 KB - PDF)
norsk (NO) (101.19 KB - PDF)
polski (PL) (89.76 KB - PDF)
português (PT) (75.52 KB - PDF)
română (RO) (135.46 KB - PDF)
slovenčina (SK) (128.09 KB - PDF)
slovenščina (SL) (118.01 KB - PDF)
Suomi (FI) (99.61 KB - PDF)
svenska (SV) (102.22 KB - PDF)
Atorvastatin : List of nationally authorised medicinal products - PSUSA/00010347/202310
English (EN) (891.49 KB - PDF)